CMCC

03/02/2018

Major milestone for Canadian cannabis company & CMCC member Peace Naturals!

Ma*****na producer makes its debut on the U.S. exchange despite nagging doubts among American investors

11/24/2017

"Canada is about to take a welcome step towards the regulation and taxation of adult recreational use of cannabis, but this shouldn’t come at the expense of the hundreds of thousands of critically and chronically ill Canadians who currently benefit from the use of medical cannabis."

The Canadian Medical Cannabis (CMCC) was pleased to see the federal government release an ambitious set of regulatory recommendations concerning both recreational and medical cannabis in Canada, and we look forward to the opportunity to consult with the government on this important issue in the comi

11/15/2017

Philippe Lucas, CMCC executive director, joined a panel discussion on policies in Canada hosted by Public Affairs Association of Canada today.

11/10/2017

"We strongly oppose extending the proposed 10% excise tax on recreational cannabis to medical cannabis, thereby increasing the cost to critically and chronically ill Canadians who benefit from its use, many of whom are on fixed income and already struggling to cover the cost of medical cannabis."

Today, the Canadian Medical Cannabis Council released a statement on the Canadian government's proposed 10% excise tax on medical cannabis.

11/08/2017

Today, the Coalition for Responsible Cannabis Branding released the Adult Use Cannabis Advertising and Marketing Guidelines for Licensed Producers. The proposed guidelines, which if endorsed by government, would come into effect following the legalization of adult consumer use of cannabis in July 2018, are designed to protect youth and the safety of all Canadians, while also ensuring that Licensed Producers can compete effectively with Canada's thriving illicit market.

10/05/2017

"The law as proposed would criminalize Canadians who use medical cannabis responsibly – even when they are not actually impaired."

Recently, the House of Commons Standing Committee on Justice and Human Rights has focused its attention on Bill C-46, which will tighten impaired driving laws, particularly cannabis impaired drivin…

09/11/2017

Today, Philippe Lucas, CMCC’s executive director and Tilray's vice-president of patient access and research, met with the House of Commons Health Committee as part of its full-day hearings on Bill C-45, the federal government’s legalization of cannabis for recreational use. Lucas urged the committee to remove taxes on medical cannabis, shared data on the substitution of cannabis for opioids and alcohol, and suggested responsible branding directed at adults would maximize the benefit of legalization by helping to differentiate between legal and illegal supply.

08/18/2017

Acceptance of medical cannabis took another step forward with the announcement of WorkSafeNB’s stakeholder consultation on a new policy on using ma*****na for medical purposes. While the policy is conservative (allowing only products rich in CBD), we’d like to congratulate WorkSafeNB on providing patients with another safe option in health care.

06/22/2017

A coalition of leading Canadian academics and researchers is calling on federal policymakers to ensure cannabis research and evaluation are prioritized in order to guide health policy related to the federal government’s plans to legalize and regulate the adult use of cannabis.

Leading Canadian researchers call on federal government to prioritize research to maximize benefits and mitigate harms of legal cannabis Vancouver, BC [June 19, 2017]—A coalition of leading Canadian academics and researchers is calling on federal policymakers to ensure cannabis research and evalu

05/27/2017

Study shows lower rates of and among patients who supplement or replace treatment with medical :

Lower rates of depression and anxiety among patients who supplement or replace treatment with medical cannabis.

05/27/2017

Learn about the Canadian Medical Council, our member LPs and Patient Advisory Committee at the Lift Expo this weekend! Stop by for medical accessories.

05/03/2017

Congratulations to The Peace Naturals Project on receiving their certificate for Good Manufacturing Practices!

– Cronos Group Inc. (TSXV:MJN) (“Cronos” or the “Company”) is pleased to announce that following a comprehensive audit, the Company’s wholly owned licensed producer (“LP”), the Peace Naturals Project Inc. (“Peace”), has been issued a Good Manufacturing Practice (“GMP”) certification in accordance wi...

04/26/2017

“In Canada, no prescription drugs are taxed and neither should medical *****na,” Philippe Lucas. “It’s something that we’ve been working on for a number of years in our lobbying efforts in Ottawa and we really do hope and anticipate that prior to passing the final stages of legalization that Canada will remove the taxes.”

04/13/2017

“It is vital that public and private drug insurance providers work to provide coverage for in a manner consistent with other medical products.”- Philippe Lucas, Executive Director of the CMCC.

April 13, 2017 - Ottawa, ON – Philippe Lucas, Executive Director of the Canadian Medical Cannabis Council (CMCC) CMCC today released the following statement regarding the release of the proposed cannabis legislation: “We applaud the federal government for its announcement today that protect

03/28/2017

Delta 9 Bio-Tech exploring storefront options to serve legal market:

"This is a very large market opportunity, something that'll we'll be eager to explore over the next few years as we have more guidance from our federal government..."

03/14/2017

Welcoming the Gastrointestinal Society as the newest member of our Patient Advisory Committee!

Gastrointestinal Society of Canada joins CMCC's Patient Advisory Committee

03/13/2017

Long-term Study Reveals No Link Between Use and Cardiovascular Disease:

02/15/2017

Data has indicated that deficiencies in function may be a contributing factor in .